Yazdanparast H - Search Results

1

Rejection of adoptively transferred Eµ-TCL1 chronic lymphocytic leukemia cells in C57BL/6 substrains or knockout mouse lines.

Öztürk S, Roessner PM, Schulze-Edinghausen L, Yazdanparast H, Kalter V, Lichter P, Hanna BS, Seiffert M. Öztürk S, et al. Among authors: yazdanparast h. Leukemia. 2019 Jun;33(6):1514-1539. doi: 10.1038/s41375-018-0332-5. Epub 2019 Jan 11. Leukemia. 2019. PMID: 30635627 No abstract available.

2

Control of chronic lymphocytic leukemia development by clonally-expanded CD8⁺ T-cells that undergo functional exhaustion in secondary lymphoid tissues.

Hanna BS, Roessner PM, Yazdanparast H, Colomer D, Campo E, Kugler S, Yosifov D, Stilgenbauer S, Schmidt M, Gabriel R, Lichter P, Seiffert M. Hanna BS, et al. Among authors: yazdanparast h. Leukemia. 2019 Mar;33(3):625-637. doi: 10.1038/s41375-018-0250-6. Epub 2018 Sep 28. Leukemia. 2019. PMID: 30267008

3

TBET-expressing Th1 CD4⁺ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 mice.

Roessner PM, Hanna BS, Öztürk S, Schulz R, Llaó Cid L, Yazdanparast H, Scheffold A, Colomer D, Stilgenbauer S, Lichter P, Seiffert M. Roessner PM, et al. Among authors: yazdanparast h. Br J Haematol. 2020 Apr;189(1):133-145. doi: 10.1111/bjh.16316. Epub 2019 Nov 14. Br J Haematol. 2020. PMID: 31724172 Free article.

4

Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice.

Hanna BS, Yazdanparast H, Demerdash Y, Roessner PM, Schulz R, Lichter P, Stilgenbauer S, Seiffert M. Hanna BS, et al. Among authors: yazdanparast h. Haematologica. 2021 Apr 1;106(4):968-977. doi: 10.3324/haematol.2019.238154. Haematologica. 2021. PMID: 32139435 Free PMC article.

5

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.

Hanna BS, McClanahan F, Yazdanparast H, Zaborsky N, Kalter V, Rößner PM, Benner A, Dürr C, Egle A, Gribben JG, Lichter P, Seiffert M. Hanna BS, et al. Among authors: yazdanparast h. Leukemia. 2016 Mar;30(3):570-9. doi: 10.1038/leu.2015.305. Epub 2015 Nov 2. Leukemia. 2016. PMID: 26522085

6

Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.

Lee-Vergés E, Hanna BS, Yazdanparast H, Rodríguez V, Rodríguez ML, Giró A, Vidal-Crespo A, Rosich L, Amador V, Aymerich M, Villamor N, Delgado J, Lichter P, Pérez-Galán P, López-Guerra M, Campo E, Seiffert M, Colomer D. Lee-Vergés E, et al. Among authors: yazdanparast h. Int J Cancer. 2019 Jun 1;144(11):2762-2773. doi: 10.1002/ijc.32010. Epub 2019 Jan 16. Int J Cancer. 2019. PMID: 30468254 Free article.

7

A novel cloning strategy for one-step assembly of multiplex CRISPR vectors.

Zuckermann M, Hlevnjak M, Yazdanparast H, Zapatka M, Jones DTW, Lichter P, Gronych J. Zuckermann M, et al. Among authors: yazdanparast h. Sci Rep. 2018 Nov 30;8(1):17499. doi: 10.1038/s41598-018-35727-3. Sci Rep. 2018. PMID: 30504793 Free PMC article.

8

Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies.

Hardt K, Heick SB, Betz B, Goecke T, Yazdanparast H, Küppers R, Servan K, Steinke V, Rahner N, Morak M, Holinski-Feder E, Engel C, Möslein G, Schackert HK, von Knebel Doeberitz M, Pox C; Peter Propping; German HNPCC consortium; Hegemann JH, Royer-Pokora B. Hardt K, et al. Among authors: yazdanparast h. Fam Cancer. 2011 Jun;10(2):273-84. doi: 10.1007/s10689-011-9431-4. Fam Cancer. 2011. PMID: 21404117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page